Development of human dermal epithelial cell-based bioassay for the dioxins

Area of Science:

• Environmental Toxicology
• Biotechnology
• Human Cell-Based Assays

Background:

• Existing bioassays for xenobiotic exposure lack completeness due to species-specific responses.
• Human cell-based bioassays offer greater relevance for assessing human biological impact.
• Dioxins and related compounds pose significant environmental and health concerns.

Purpose of the Study:

• To develop a human epidermal cell-based bioassay for detecting and quantifying dioxins and related compounds.
• To establish a reliable system for estimating toxic equivalency (TEQ) values.
• To provide a tool for understanding interspecies differences in dioxin toxicity.

Main Methods:

• Development of a human keratinocyte cell line stably transfected with a luciferase reporter gene under dioxin-inducible control (DREs).
• Dose-response analysis of luciferase activity upon exposure to dioxins and related compounds.
• Evaluation of assay performance including EC50, detection limit, and optimal exposure time.
• Comparison of assay results with established Toxic Equivalent Factor (TEF) values.

Main Results:

• The bioassay demonstrated a consistent dose-response relationship for luciferase activity with a half effective dose (EC50) of 200 pM.
• The assay exhibited a minimum detection limit of 10 pM and an optimal exposure time of 24 hours.
• The system showed parallel dose-response curves for various aryl hydrocarbon receptor agonists, enabling TEQ estimation.
• Relative induction potencies correlated well with World Health Organization (WHO)-TEF values.

Conclusions:

• The developed human cell-based bioassay is an efficient screening tool for quantifying TEQ values of dioxin-like chemicals.
• This assay provides a direct human-relevant system for assessing biological impact of xenobiotic exposure.
• The bioassay can contribute to understanding interspecies differences in dioxin toxicity and risk assessment.